Positron emission tomography with [ 18F]-DPA-714 unveils a smoldering component in most multiple sclerosis lesions driving disease progression
Mariem Hamzaoui(Inserm), Bruno Stankoff(Pitié-Salpêtrière Hospital), Céline Louapre(Inserm), Vito A. G. Ricigliano(Inserm), Giacomo Boffa(Centre National de la Recherche Scientifique), Andrea Lazzarotto(Centre National de la Recherche Scientifique), Benedetta Bodini(Inserm), Arya Yazdan Panah(Centre National de la Recherche Scientifique), Théodore Soulier(Centre National de la Recherche Scientifique)
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
August 14, 2024
Cited by 0
Related Papers
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Brain atrophy and lesion load predict long term disability in multiple sclerosis
|Journal of Neurology Neurosurgery & Psychiatry|2013|327
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293